Necrotic myopathy (Q103465): Difference between revisions

← Older edit

@@ Property / Canonical URI @@
+https://id.who.int/icd/entity/124501922
@@ Property / Canonical URI: https://id.who.int/icd/entity/124501922 / rank @@
+Normal rank
@@ Property / CURIE @@
+CID11:ID_124501922
@@ Property / CURIE: CID11:ID_124501922 / rank @@
+Normal rank
@@ Property / Canary Token @@
+dki-india-ID_124501922
@@ Property / Canary Token: dki-india-ID_124501922 / rank @@
+Normal rank
@@ Property / Verification Status @@
+Concluído
@@ Property / Verification Status: Concluído / rank @@
+Normal rank
@@ Property / Knowledge Architect @@
+https://pauloleads.com.br/cases-publicos/
+Normal rank
@@ Property / Collection date @@
+August 2026Timestamp +2026-08-16T00:00:00Z
Timezone +00:00
Calendar Gregorian
Precision 1 day
Before 0
After 0
-Timestamp
++2026-08-16T00:00:00Z
-Timezone
++00:00
-Calendar
+Gregorian
-Precision
+day
 Before
 After
@@ Property / Collection date: 16 August 2026 / rank @@
+Normal rank

Latest revision as of 09:13, 17 August 2026

Group of myopathic disorders characterized by the predominant pathological feature of necrosis of muscle fibers in the absence of substantial lymphocytic inflammatory infiltrates. Most commonly divided into immune-mediated (IMNM) and non-immune mediated (NIMNM). Both IMNM and NIMNM are typically characterized by proximal weakness, although the severity can vary.

Language	Label	Description	Also known as
default for all languages	ID_124501922
English	Necrotic myopathy	Group of myopathic disorders characterized by the predominant pathological feature of necrosis of muscle fibers in the absence of substantial lymphocytic inflammatory infiltrates. Most commonly divided into immune-mediated (IMNM) and non-immune mediated (NIMNM). Both IMNM and NIMNM are typically characterized by proximal weakness, although the severity can vary.